EUVIMEDEUVIMED entdecken
Crossref

Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases

Kozo Kataoka iD, Kanae Takahashi, Jiro Takeuchi iD, Kazuma Ito, Naohito Beppu, Wim Ceelen iD, Yukihide Kanemitsu iD, Yoichi Ajioka, Itaru Endo iD, Kiyoshi Hasegawa, Keiichi Takahashi, Masataka Ikeda

British Journal of Surgery · 12.06.2023 · 110 (7) · 864-869

DOI: 10.1093/bjs/znad127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 17.05.2023. Verfasst von Kozo Kataoka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Lower Gastrointestinal, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Hyogo College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of recurrence-free survival (RFS) as a valid surrogate endpoint for overall survival (OS) in patients who underwent upfront surgery for colorectal liver metastases remains uncertain. The aim of the study was to compare the two survival measures in a nationwide cohort of upfront resected colorectal liver metastasis.

Methods

Data from patients with colorectal liver metastases without extrahepatic metastases who underwent curative surgery for liver metastases were retrieved from the Japanese nationwide database (data collection 2005–2007 and 2013–2014). RFS, OS, and survival after recurrence were estimated using the Kaplan–Meier method. The correlation (ρ) between RFS and OS was assessed using the rank correlation method combined with iterative multiple imputation, to account for censoring. As a secondary analysis, the correlation was evaluated according to adjuvant chemotherapy regimen. In sensitivity analysis, the pairwise correlation between RFS and OS was calculated.

Results

A total of 2385 patients with colorectal liver metastases were included. In the primary analysis, there was a moderately strong correlation between RFS and OS (ρ = 0.73, 95 per cent c.i. 0.70 to 0.76). The strength of the correlation was similar regardless of the adjuvant treatment regimen (oxaliplatin plus 5-fluorouracil: ρ = 0.72, 0.67 to 0.77; 5-fluorouracil alone: ρ = 0.72, 0.66 to 0.76; observation: ρ = 0.74, 0.69 to 0.78). The mean(s.d.) pairwise correlation coefficient between 3-year RFS and 5-year OS was 0.87(0.06).

Conclusion

In surgically treated patients with colorectal liver metastases, there was a moderately strong correlation between RFS and OS, which was unaffected by the treatment regimen. Further validation using a trial-level analysis is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsHumansDisease-Free SurvivalOxaliplatinFluorouracilChemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsHepatectomy

Substanzen

OxaliplatinFluorouracil

Autor:innen und Institutionen

  • Division of Lower Gastrointestinal, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Biostatistics, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Clinical Epidemiology, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Gastrointestinal Surgery, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Department of Colorectal Surgery, National Cancer Centre Hospital, Tokyo, Japan.
  • Division of Molecular and Diagnostic Pathology, Niigata University, Graduate School of Medical and Dental Sciences, Niigata, Japan.

ORCID-Profile: Kozo Kataoka, Jiro Takeuchi, Wim Ceelen, Yukihide Kanemitsu, Itaru Endo

Förderung

  • Hyogo College of Medicine

Zitieren

APA

Kataoka, K., Takahashi, K., Takeuchi, J., Ito, K., Beppu, N., Ceelen, W., Kanemitsu, Y., Ajioka, Y., Endo, I., Hasegawa, K., Takahashi, K., & Ikeda, M. (2023). Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases. British Journal of Surgery, 110(7), 864-869. https://doi.org/10.1093/bjs/znad127

Vancouver

Kataoka K, Takahashi K, Takeuchi J, Ito K, Beppu N, Ceelen W, et al. Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases. British Journal of Surgery. 2023;110(7):864-869. doi:10.1093/bjs/znad127

BibTeX
@article{Kataoka2023,
  author = {Kataoka, Kozo and Takahashi, Kanae and Takeuchi, Jiro and Ito, Kazuma and Beppu, Naohito and Ceelen, Wim and Kanemitsu, Yukihide and Ajioka, Yoichi and Endo, Itaru and Hasegawa, Kiyoshi and Takahashi, Keiichi and Ikeda, Masataka},
  title = {Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases},
  journal = {British Journal of Surgery},
  year = {2023},
  volume = {110},
  number = {7},
  pages = {864--869},
  doi = {10.1093/bjs/znad127}
}
Kostenlos starten →